Nuix Limited (ASX:NXL), a provider of investigative analytics and intelligence software, has seen its share price decline over the past year despite reporting higher Earnings and a return to statutory profit. Nuix Limited (ASX:NXL) shares were priced at $1.76, down 7.37% in today’s session, and are down 41.53% over the past year. The company announced its results for the year ended 30 June 2026 (FY26) on 24 August 2026.

For context, the S&P/ASX 200 Info Tech [XIJ] (INDEXASX: XIJ) stood at 1,684.00, down 2.90% (−50.30 points) today as of 6 Oct, and is down 42.73% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) today, and is down 2.74% over the past year.

Business Model and Operational Footprint

Nuix develops software that processes and analyses large volumes of complex, unstructured data for investigations, compliance, privacy and AI use cases. Its main product, Nuix Neo, is a platform that includes a governed data layer and an architecture that allows customers to use their own AI models. The Discover product is positioned in a separate go-to-market team. The company is headquartered in Sydney, Australia.

Revenue is subscription based and measured by annualised contract value (ACV). Nuix Neo ACV rose 179% to $78.5 million across 135 customers, representing 30% of total ACV. On 20 April 2026 the company completed the Acquisition of Linkurious, a graph visualisation business, which contributed an annualised ACV run rate of $12.0 million at 30 June 2026. Nuix states that it has more than 10,000 target accounts globally with penetration of less than 10%.

Sector Dynamics

Demand for Data Analytics and investigation software is linked to regulatory activity, litigation volumes, data privacy requirements and enterprise AI deployment. Nuix notes that growing enterprise requirements for data sovereignty and control, as well as governed inputs to AI workflows, are relevant to its product design. Vendors across the sector are also shifting from feature sales to platform pricing and are introducing AI modules as discrete options.

Nuix’s 41.53% one-year decline compares with a 42.73% decline in the S&P/ASX 200 Info Tech index. Among ASX peers, Hansen Technologies Ltd (ASX:HSN) is down 43.79% and Objective Corporation Ltd (ASX:OCL) is down 71.01% over the same period. Today Nuix shares are down 7.37% at $1.76, compared with a 2.90% decline for the index.

FY26 Results Release

ACV was $260.0 million, up 13.9%, within the guided range, with organic ACV growth of 8.6% (11.1% in constant currency). Revenue was $263.2 million, up 18.8%, and multi-year deals represented 35% of revenue, up from 27%. Adjusted management EBITDA was $59.8 million, up 60.4%, with the Margin rising to 22.7% from 16.8%. Statutory EBITDA was $66.9 million, and statutory NPAT was $16.4 million, compared with a loss of $9.2 million.

Underlying Cash Flow was $51.0 million, up 154%, and free cash flow was $37.4 million, compared with $4.0 million. Net cash was $49.9 million after Linkurious financial close. Net dollar retention was 105.2% at year end, up from 101.0% at the half, and churn was 6.6%, improved on the prior year but higher than at the half.

Nuix restructured its go-to-market, with two regional sales teams, a Chief Customer Officer and a sales enablement function, operational from FY27. Product and technology teams were unified under the CTO, and a one-off R&D Accelerator Investment of $15 million in FY27 will target enterprise integration, agentic AI, cloud, user interface and innovation cadence. The Federal Court dismissed all claims by ASIC against the company and the then directors. ASIC has appealed only as it concerns the company, and the appeal is pending.

Growth Catalysts and Critical Operating Risks

Growth catalysts identified include migration of customers to Nuix Neo, cross-selling with Linkurious, a platform-oriented sales approach, AI modules and rising Demand for data sovereignty. The company states that revenue growth significantly exceeded cost growth in FY26.

Operating risks include the pending ASIC appeal, a one-off $15 million R&D Accelerator spend in FY27, execution of the sales restructure, churn of 6.6%, and the lower organic ACV growth rate of 8.6% compared with total growth. Linkurious integration, foreign exchange movements and the reliance on multi-year deals for revenue growth are further variables. ACV was within, rather than above, the guided range.

Nuix states that its AI approach includes dedicated AI roles, model-agnostic tooling and “Digital FTEs” as a measure of return, and that the approach is designed to scale capacity rather than reduce headcount. The company also separated Discover into its own go-to-market team and describes the new sales structure as essentially cost-neutral apart from one-off restructuring costs.

Where Things Stand

Nuix reports higher profit, cash generation and Nuix Neo adoption, with its shares lower over twelve months and in today’s session. Reference points ahead include the ASIC appeal, FY27 delivery of the R&D Accelerator and half-year results.